Medicare Enrolled

Dr. Clara De Jesus Kalil, M.D.

Dermatology · Ocala, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
7860 SW 103RD ST. RD., Ocala, FL 34476
3528734458
In practice since 2008 (17 years)
NPI: 1528218971 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. De Jesus Kalil from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. De Jesus Kalil? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. De Jesus Kalil

Dr. Clara De Jesus Kalil is a dermatology in Ocala, FL, with 17 years in practice. Based on federal Medicare data, Dr. De Jesus Kalil performed 24,122 Medicare services across 12,553 unique beneficiaries.

Between the years covered by Open Payments, Dr. De Jesus Kalil received a total of $450 from 6 pharmaceutical and/or device companies across 8 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. De Jesus Kalil is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice▲ Top 0% volume in FL$ $450 industry payments

Medicare Practice Summary

Medicare Utilization ↗
24,122
Medicare services
Top 0% in FL for dermatology
12,553
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,419 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)4,800$18$25
Blood draw (venipuncture)1,358$8$15
Complete blood count (CBC) with differential1,259$8$20
Office visit, established patient (30-39 min)1,143$91$155
Hemoglobin A1c test (diabetes monitoring)1,135$10$20
Basic metabolic blood panel1,121$8$30
Free thyroxine (T4) test1,085$9$20
Thyroid stimulating hormone (TSH) test1,085$16$30
Thyroid hormone, t3 measurement, total1,084$14$30
Lipid panel (cholesterol and triglycerides)1,032$13$30
Ldl cholesterol level1,028$10$21
Liver function blood test panel985$8$30
Office visit, established patient (20-29 min)742$67$105
Chronic care management, first 20 min/month602$46$95
Annual alcohol misuse screening, 5 to 15 minutes593$18$27
Annual depression screening593$18$27
Electrocardiogram (EKG), 12-lead401$10$45
Chest X-ray, 2 views380$23$75
Urinalysis, manual374$3$5
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous322$18$30
Urine microalbumin (protein) analysis295$6$10
Creatinine test (kidney function)293$5$10
Complete ultrasound scan behind abdominal cavity245$77$270
Bone density scan (DEXA)169$36$200
Echocardiogram, transthoracic146$136$500
Vitamin D level test136$29$60
Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage106$22$29
Flu vaccine administration106$30$35
PSA test (prostate cancer screening)101$18$40
Albumin (protein) level93$5$10
Bilirubin level, total93$5$10
Phosphatase (enzyme) level, alkaline93$5$10
Total protein level, blood93$4$10
Liver enzyme (sgot), level93$5$10
Liver enzyme (sgpt), level93$5$10
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle80$55$100
Prostate cancer screening; prostate specific antigen test (psa)55$19$40
Inhalation treatment for airway obstruction or sputum production52$7$25
X-ray of lower and sacral spine, 2-3 views50$30$79
Test to measure expiratory airflow and volume changes before and after medication administration49$29$90
Test to measure largest amount of air breathed in an out49$11$38
Test to determine lung volumes using gas dilution or washout49$32$65
Test to examine how well the lungs exchange gases49$42$80
Comprehensive metabolic blood panel40$10$30
Hip X-ray, 2-3 views32$34$61
New patient office visit (30-44 min)32$67$160
Ultrasound of both sides of head and neck blood flow26$138$435
X-ray of upper spine, 4-5 views23$39$78
Shoulder X-ray, 2+ views22$27$49
Testing for presence of drug, read by direct observation22$12$50
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional21$49$265
X-ray of knee, 1-2 views19$26$46
Magnesium level test18$7$15
Transitional care management services for problem of at least moderate complexity17$158$260
Cervical or vaginal cancer screening; pelvic and clinical breast examination17$39$55
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory17$41$70
Removal of impacted ear wax16$33$92
Foot X-ray, 3+ views15$26$45
Complete ultrasound scan of abdomen13$83$250
Pneumonia vaccine administration13$30$35
Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and13$40$150
Injection, methylprednisolone acetate, 80 mg13$9$20
Transitional care management services for problem of high complexity12$214$360
Ultrasound of leg arteries or artery grafts11$182$500
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
21.5% medium
77.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$450
Total received (2018-2024)
Avg $112/year across 4 years
Top 45% in FL for dermatology
6
Companies
8
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$450 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$144
2022
$157
2019
$102
2018
$47

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Janssen Pharmaceuticals, Inc
$124
E.R. Squibb & Sons, L.L.C.
$121
Amgen Inc.
$102
Medtronic Vascular, Inc.
$47
GlaxoSmithKline, LLC.
$35
PFIZER INC.
$20
Top 3 companies account for 77.3% of total payments
Associated products mentioned in payments ›
ClosureFast · OPDIVO · PREVNAR 20 · Repatha · SHINGRIX · VenaSeal · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for a dermatology in Ocala?
Compare dermatologys in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse dermatologys nearby

Geographic Context

Dermatologys within 10 mi
79
Per 100K population
20.4
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
4.7 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. De Jesus Kalil is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and low-engagement industry engagement, with 17 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. De Jesus Kalil experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. De Jesus Kalil performed 4,800 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. De Jesus Kalil receive payments from pharmaceutical companies?
Yes. Dr. De Jesus Kalil received a total of $450 from 6 companies across 8 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. De Jesus Kalil's costs compare to other dermatologys in Ocala?
Dr. De Jesus Kalil's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. De Jesus Kalil) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →